# US 2023/0067014 A1 · Compensating for changes in potency of a medicament in a medicament delivery device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0067014 A1
- Document ID: US20230067014A1
- Status: Published application
- Kind: A1
- Application number: 17/821,989
- Filed: 2022-08-24
- Published: 2023-03-02
- Earliest claimed: 2021-08-30
- Assignees: Insulet Corporation
- Applicants: Insulet Corporation
- Inventors: Joon Bok LEE; John D'ARCO; David NAZZARO; Yibin ZHENG; Jason O'CONNOR
- Web page: https://patentgrep.com/patent/US20230067014A1

## CPC

- A61M 5/31546: {Electrically operated dose setting, e.g. input via touch screen or plus/minus buttons}
- G16H 20/17: delivered via infusion or injection
- A61M 5/20: Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically (A61M5/142 takes precedence)
- G16H 40/63: for local operation
- A61M 5/14248: {of the skin patch type}
- A61M 2005/14208: {with a programmable infusion control system, characterised by the infusion program}
- A61M 2202/0486: Glucose
- A61M 2205/3368: Temperature
- A61M 2205/50: with microprocessors or computers
- A61M 2230/201: Glucose concentration
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

The exemplary embodiments may account for a change in potency of a medicament and adjust the dosage of medicament delivered to a user via a medicament delivery device to compensate for the change in potency. The medicament delivery device may determine the amount of change in the potency in the medicament and may make the adjustment in dosage of the medicament delivered to the user automatically without user input. The net result in that the dosage of medicament delivered to the user is better matched to the user's true need for the medicament.

## Claims

### Claim 1

A method performed by a processor of an electronic device, comprising:
calculating a basal dosage of a medicament to be delivered to a user by a medicament delivery device;
determining an amount that at least one factor affects a potency of the medicament; and
adjusting the calculated basal dosage of the medicament to compensate for the determined amount that the at least one factor has affected the potency of the medicament.

### Claim 2 (depends on 1)

The method of claim 1, wherein the medicament is insulin.

### Claim 3 (depends on 1)

The method of claim 1, wherein the at least one factor comprises temperature, exposure to light or exposure to air.

### Claim 4 (depends on 1)

The method of claim 1, wherein the at least one factor comprises a duration of time that the medicament has been stored in the medicament delivery device.

### Claim 5 (depends on 1)

The method of claim 1, wherein the at least one factor decreases the potency of the medicament and the calculated dosage is adjusted to a larger dosage to compensate.

### Claim 6 (depends on 1)

The method of claim 1, wherein the at least one factor comprises temperature, an average temperature or a histogram of temperatures and a duration of time that the medicament has been stored in the medicament delivery device at a particular temperature or at a particular average temperature.

### Claim 7 (depends on 1)

The method of claim 1, wherein the adjusting comprises adjusting the calculated basal dosage based on how much a current temperature is above a target temperature.

### Claim 8 (depends on 1)

The method of claim 1, wherein the adjusting comprises adjusting the calculated basal dosage based on how much an actual blood glucose level compares with a projected blood glucose level.

### Claim 9

A medicament delivery device, comprising:
a medicament storage;
a pump for pumping medicament out of the storage for delivery to a user;
a storage medium for storing data and computer programming instructions;
a processor for executing the computer programming instructions, the computer programming instructions causing the processor to perform the following:
calculating a basal dosage of a medicament to be delivered to a user by the medicament delivery device;
determining an amount that at least one factor affects a potency of the medicament; and
adjusting the calculated basal dosage of medicament to compensate for the determined amount that the at least one factor has affected the potency of the medicament.

### Claim 10 (depends on 9)

The medicament delivery device of claim 9, wherein the computer programming instructions additionally cause the processor to control the pump to deliver the adjusted basal dosage of medicament to the user.

### Claim 11 (depends on 9)

The medicament delivery device of claim 9, wherein the medicament is insulin.

### Claim 12 (depends on 9)

The medicament delivery device of claim 9, wherein the at least one factor comprises temperature.

### Claim 13 (depends on 9)

The medicament delivery of claim 9, wherein the at least one factor comprises a duration of time that the medicament has been stored in the medicament delivery device.

### Claim 14 (depends on 9)

The medicament delivery device of claim 9, wherein the at least one factor comprises temperature and a duration of time that the medicament has been stored in the medicament delivery device.

### Claim 15 (depends on 9)

The medicament delivery device of claim 9, wherein the adjusting comprises adjusting the calculated basal dosage based on how much an average temperature is above a target temperature.

### Claim 16 (depends on 9)

The medicament delivery device of claim 9, wherein the adjusting comprises adjusting the calculated basal dosage based on how much an actual blood glucose level compares with a projected blood glucose level.

### Claim 17

A method performed by a processor in an on-body insulin delivery device, comprising:
calculating a basal dosage for a user based on at least a current blood glucose level;
calculating how much a potency of the insulin has decreased over a time period; and
increasing the calculated basal dosage of the insulin to offset the calculated decrease in potency of the insulin.

### Claim 18 (depends on 17)

The method of claim 17, wherein calculating how much the potency of the insulin has decreased over the time period comprises determining a temperature for the insulin and adjusting for the determined temperature if the determined temperature exceeds a threshold.

### Claim 19 (depends on 18)

The method of claim 18, further comprising determining a delta of how much the determined temperature exceeds the threshold and a magnitude of the adjustment for the determined temperature is based on a magnitude of the delta.

### Claim 20 (depends on 17)

The method of claim 17, wherein calculating how much the potency of the insulin has decreased over the time period comprises determining a delta between a projected blood glucose level for the user and an actual blood glucose level for the user and determining how much the potency of the insulin has decreased based on a magnitude of the determined delta.
